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Background
Nosocomial infections are among the leading causes of
mortality and morbidity especially in neonatal intensive
care unit (NICU) [1]. The intestinal microbiota of the gut
is nowadays considered to play an important functional
role in the host’s health through nutritional, physiological
and immunological processes. For these reasons, probio-
tics may exert actions of prevention and therapy of infec-
tious diseases.
Results
The mechanisms of action of probiotics are strain speci-
fic but can be summarized mainly in three areas: changes
of gut ecology, modulation of gut mucosal barrier and
regulation of the immune response through interaction
with gut-associated immune system [2]. Several studies
regarding the supplementation of probiotics in nosoco-
mial infections have been conducted mainly in adult
population. Among pediatric studies major findings have
been observed in treatment of acute gastroenteritis, pri-
marily caused by Rotavirus [3,4], and in the prevention of
antibiotic associated diarrhea (AAD) [5]. Supplementa-
tion with probiotics has proven useful even in the treat-
ment of Clostridium difficile disease (CDD), the most
common pathogen involved in AAD [6]. Data from
meta-analysis and cochrane review on the prevention of
necrotizing enterocolitis (NEC) show an overall benefit
of probiotic supplementation [7]. The limitations of the
above cited studies are mainly related to heterogeneity in
terms of strain, dosage and duration of treatment and the
lack of studies on extremely low birth weight preterm
infants. Data on nosocomial pneumonia and ventilator-
associated pneumonia in neonatal and pediatric age is
scanty. In a large randomized, double-blind placebo con-
trolled study, Hojsak et al demonstrated that supplemen-
tation with Lactobacillus GG significantly decreased the
risk of nosocomial respiratory tract infections [8]. On the
other hand, the data from adult studies have been con-
flicting, with a tendency towards the demonstration of
probiotic efficacy in reducing the incidence of ventilator-
associated pneumonia [9]. Meticillin-resistant Staphylo-
coccus aureus is a multidrug-resistant nosocomial
pathogen; a recent review of literature [10] showed that
many probiotic strains inhibit MRSA growth in vitro.
Furthermore, this review describes that there is little pub-
lished clinical data on the use of probiotics in prophylaxis
or treatment of MRSA-mediated infections.
Conclusions
Due to the significant heterogeneity between the studies
in literature it is not possible to draw consistent conclu-
sions on extensive use of probiotics in prevention and
treatment of nosocomial infections, except for acute gas-
troenteritis, AAD, CDD and NEC.
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